Cardiology MCQ – Treatment of transthyretin amyloid cardiomyopathy

Cardiology MCQ – Treatment of transthyretin amyloid cardiomyopathy Recently developed pharmacotherapy which has been shown to halt and reverse the progression of transthyretin amyloid cardiomyopathy: Trastuzumab Tafamidis Tranexamic acid Tamoxifen Click here for the correct answer
Source: Cardiophile MD - Category: Cardiology Authors: Tags: Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs